194
Participants
Start Date
September 18, 2021
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
Surufatinib plus Toripalimab
Surufatinib is a tablet in the form of 50mg, oral, once a day; Toripalimab is an injection in the form of 240mg, intravenous, once three weeks.
5-fluorouracil, Calcium folinate and Irinotecan
Irinotecan 180 mg/m\^2, Calcium folinate 400 mg/m\^2, 5-FU total 2800 mg/m\^2 will be administrated once two weeks.
RECRUITING
Beijing Cancer Hospital, Beijing
Hutchison Medipharma Limited
INDUSTRY